Coldstream Capital Management Inc Rapt Therapeutics, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 505 shares of RAPT stock, worth $459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
505Holding current value
$459% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
103Shares Held
129MCall Options Held
184KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$20.3 Million7.04% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$12 Million0.56% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$11.9 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$11.4 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$10.7 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $27M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...